These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 17529896

  • 21. Urinary metabolites of delta 1-tetrahydrocannabinol in man.
    Halldin MM, Carlsson S, Kanter SL, Widman M, Agurell S.
    Arzneimittelforschung; 1982; 32(7):764-8. PubMed ID: 6289845
    [Abstract] [Full Text] [Related]

  • 22. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.
    Smith-Kielland A, Skuterud B, Mørland J.
    J Anal Toxicol; 1999 Sep; 23(5):323-32. PubMed ID: 10488918
    [Abstract] [Full Text] [Related]

  • 23. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME, Brine DR, Perez-Reyes M.
    Drug Metab Dispos; 1981 Sep; 9(4):369-75. PubMed ID: 6114837
    [Abstract] [Full Text] [Related]

  • 24. Profiles of delta 9-tetrahydrocannabinol metabolites in urine of marijuana users: preliminary observations by high performance liquid chromatography-radioimmunoassay.
    Alburges ME, Peat MA.
    J Forensic Sci; 1986 Apr; 31(2):695-706. PubMed ID: 3011957
    [Abstract] [Full Text] [Related]

  • 25. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
    Hoffmann M, DeMaio W, Jordan RA, Talaat R, Harper D, Speth J, Scatina J.
    Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
    [Abstract] [Full Text] [Related]

  • 26. Glucuronic acid conjugate of delta 1-tetrahydrocannabinol identified in the urine of man.
    Halldin MM, Widman M.
    Arzneimittelforschung; 1983 Sep; 33(1):177-8. PubMed ID: 6299309
    [Abstract] [Full Text] [Related]

  • 27. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL, Barriere SL, Kitt MM, Goldberg MR.
    J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659
    [Abstract] [Full Text] [Related]

  • 28. [Delta-9-tetrahydrocannabinol pharmacokinetics].
    Goullé JP, Saussereau E, Lacroix C.
    Ann Pharm Fr; 2008 Aug; 66(4):232-44. PubMed ID: 18847571
    [Abstract] [Full Text] [Related]

  • 29. Distribution of ∆(9)-Tetrahydrocannabinol and 11-Nor-9-Carboxy-∆(9)-Tetrahydrocannabinol Acid in Postmortem Biological Fluids and Tissues From Pilots Fatally Injured in Aviation Accidents.
    Kemp PM, Cardona PS, Chaturvedi AK, Soper JW.
    J Forensic Sci; 2015 Jul; 60(4):942-9. PubMed ID: 25800046
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [Abstract] [Full Text] [Related]

  • 31. [Chemical toxicological analysis of urinary cannabinoids by chromatography mass spectrometry].
    Kataev SS, Smirnova IIu, Zalesova VA, Kurdina LN.
    Sud Med Ekspert; 2000 Oct; 43(1):27-32. PubMed ID: 10703282
    [Abstract] [Full Text] [Related]

  • 32. PLasma half-life and urinary excretion of cyclophosphamide in children.
    Sladek NE, Priest J, Doeden D, Mirocha CJ, Pathre S, Krivit W.
    Cancer Treat Rep; 1980 Oct; 64(10-11):1061-6. PubMed ID: 7459891
    [Abstract] [Full Text] [Related]

  • 33. Simultaneous determination of amphetamine-type stimulants and cannabinoids in fingernails by gas chromatography-mass spectrometry.
    Kim JY, Cheong JC, Kim MK, Lee JI, In MK.
    Arch Pharm Res; 2008 Jun; 31(6):805-13. PubMed ID: 18563365
    [Abstract] [Full Text] [Related]

  • 34. Investigation of the transformation of 11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol during water chlorination by liquid chromatography-quadrupole-time-of-flight-mass spectrometry.
    González-Mariño I, Rodríguez I, Quintana JB, Cela R.
    J Hazard Mater; 2013 Oct 15; 261():628-36. PubMed ID: 23995559
    [Abstract] [Full Text] [Related]

  • 35. Using sweeping micellar electrokinetic chromatography to analyze Delta9-tetrahydrocannabinol and its major metabolites.
    Su HL, Feng LI, Jen HP, Hsieh YZ.
    J Chromatogr A; 2009 Apr 17; 1216(16):3512-7. PubMed ID: 18945437
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB, Dowell JA, Pratt RD.
    Clin Ther; 2007 Jul 17; 29(7):1368-80. PubMed ID: 17825688
    [Abstract] [Full Text] [Related]

  • 37. Human kinetics of orally and intravenously administered low-dose 1,2-(13)C-dichloroacetate.
    Jia M, Coats B, Chadha M, Frentzen B, Perez-Rodriguez J, Chadik PA, Yost RA, Henderson GN, Stacpoole PW.
    J Clin Pharmacol; 2006 Dec 17; 46(12):1449-59. PubMed ID: 17101744
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug 17; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 39. Metabolism and disposition of delta-9-tetrahydrocannabinol in man.
    Lemberger L, Axelrod J, Kopin IJ.
    Pharmacol Rev; 1971 Dec 17; 23(4):371-80. PubMed ID: 4943951
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.